Osimertinib

Development of drug resistance in lung adenocarcinoma: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Kim RH, et al. Prevalence of the EGFR T790M and other resistance mutations in the Australian population and histopathological correlation in a small subset of cases. Pathology 52: 410-420, No. 4, Jun 2020. Available from: URL: http://doi.org/10.1016/j.pathol.2020.03.003

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Osimertinib. Reactions Weekly 1809, 199 (2020). https://doi.org/10.1007/s40278-020-79983-y

    Download citation